Read + Share
Verstappen M, van Steenbergen HW, de Jong PHP, van der Helm-van Mil AHM, et al. Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup
of patients with a strong clinical and serological response to initiation of
DMARD treatment favor disease resolution. Arthritis Res Ther 2022;24:4.
PMID: 34980246
|
 |
|
